Julia Zack Selected Research

Julia Zack Research Topics

2	Type 2 Diabetes Mellitus (MODY) 01/2015 - 04/2013
1	Asthma (Bronchial Asthma) 02/2024
1	Nasal Polyps (Nasal Polyp) 02/2024
1	Chronic Urticaria 02/2024
1	Rhinosinusitis 02/2024
1	Cystic Fibrosis (Mucoviscidosis) 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Headache (Headaches) 10/2023
1	Fascioliasis 10/2023
1	Leukemia 01/2022
1	Dyslipidemias (Dyslipidemia) 04/2013
1	Pulmonary Arterial Hypertension 12/2012

1	Omalizumab (Xolair)FDA Link 02/2024
1	anti-IgE antibodiesIBA 02/2024
1	Monoclonal AntibodiesIBA 02/2024
1	icenticaftorIBA 01/2024
1	Desipramine (Pertofrane)FDA LinkGeneric 10/2023
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2023
1	TriclabendazoleIBA 10/2023
1	asciminibIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2015
1	Ranolazine FDA Link 01/2015
1	Nonesterified Fatty Acids (NEFA)IBA 04/2013
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2013
1	2- (6- ((2- hydroxycyclopentyl)amino)purin- 9- yl)- 5- ((2- fluorophenylthio)methyl)oxolane- 3,4- diolIBA 04/2013
1	Bosentan (Tracleer)FDA Link 12/2012
1	Endothelin Receptor AntagonistsIBA 12/2012
1	ambrisentan FDA Link 12/2012

1	Therapeutics 04/2013